Companies concluded memorandum of understanding that Takeda will continue to provide distribution support for the Moderna COVID-19 vaccines for a transitional period
Dupixent would be the first and only medicine specifically indicated to treat prurigo nodularis in the U.S., if approved
Auld is a seasoned Financial Executive with over 30 years of relevant experience
Avillion announces expansion of partnership with AstraZeneca on PT027 and will fund and execute a new Phase 3b study
Trial will assess safety and antibody responses of NVX-CoV2515 to the Omicron variant of COVID-19
Glenmark Pharmaceuticals announced its financial results for the fourth quarter ended March 31, 2022
The abstract is about the cohort A, stage I of the ongoing global phase ? trial that evaluating the safety and efficacy of Catumaxomab in advanced GC patients with peritoneal metastasis
The ABDM public dashboard is a one-stop solution for information on the mission’s progress up to state/UT level
The inspection was a Pre-Approval cum cGMP inspection and it covered 15 ANDAs
The company’s annual sales grew from Rs 548.12 crore in FY 2020-21 to Rs 598.65 crore this fiscal
Subscribe To Our Newsletter & Stay Updated
